X-108175676-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_033641.4(COL4A6):āc.2808T>Cā(p.Arg936Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.99 ( 37790 hom., 31144 hem., cov: 21)
Exomes š: 1.0 ( 366039 hom. 360845 hem. )
Failed GnomAD Quality Control
Consequence
COL4A6
NM_033641.4 synonymous
NM_033641.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.661
Genes affected
COL4A6 (HGNC:2208): (collagen type IV alpha 6 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant X-108175676-A-G is Benign according to our data. Variant chrX-108175676-A-G is described in ClinVar as [Benign]. Clinvar id is 258270.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-108175676-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.661 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 107755AN: 109254Hom.: 37795 Cov.: 21 AF XY: 0.988 AC XY: 31092AN XY: 31456 FAILED QC
GnomAD3 genomes
AF:
AC:
107755
AN:
109254
Hom.:
Cov.:
21
AF XY:
AC XY:
31092
AN XY:
31456
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.996 AC: 177999AN: 178727Hom.: 57060 AF XY: 0.997 AC XY: 63348AN XY: 63517
GnomAD3 exomes
AF:
AC:
177999
AN:
178727
Hom.:
AF XY:
AC XY:
63348
AN XY:
63517
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.999 AC: 1093996AN: 1095545Hom.: 366039 Cov.: 31 AF XY: 0.999 AC XY: 360845AN XY: 361261
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
1093996
AN:
1095545
Hom.:
Cov.:
31
AF XY:
AC XY:
360845
AN XY:
361261
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.986 AC: 107797AN: 109295Hom.: 37790 Cov.: 21 AF XY: 0.988 AC XY: 31144AN XY: 31507
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
107797
AN:
109295
Hom.:
Cov.:
21
AF XY:
AC XY:
31144
AN XY:
31507
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 09, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 03, 2025 | - - |
Hearing loss, X-linked 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at